Aspirin and lidocaine blunt pain in crabs and lobsters, raising hard questions about how they are treated before reaching your plateOctober 8, 2026
General Laverock Therapeutics announces in vivo programmes in oncology and genetic medicineBy Healthcare Propulsion StaffSeptember 30, 20260 Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announces its…
